IBDEI1TH ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30868,1,3,0)
 ;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr
 ;;^UTILITY(U,$J,358.3,30868,1,4,0)
 ;;=4^T43.205D
 ;;^UTILITY(U,$J,358.3,30868,2)
 ;;=^5050541
 ;;^UTILITY(U,$J,358.3,30869,0)
 ;;=T43.205S^^123^1540^6
 ;;^UTILITY(U,$J,358.3,30869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30869,1,3,0)
 ;;=3^Antidepressant Discontinuation Syndrome,Sequela
 ;;^UTILITY(U,$J,358.3,30869,1,4,0)
 ;;=4^T43.205S
 ;;^UTILITY(U,$J,358.3,30869,2)
 ;;=^5050542
 ;;^UTILITY(U,$J,358.3,30870,0)
 ;;=G25.71^^123^1540^7
 ;;^UTILITY(U,$J,358.3,30870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30870,1,3,0)
 ;;=3^Medication-Induced Acute Akathisia
 ;;^UTILITY(U,$J,358.3,30870,1,4,0)
 ;;=4^G25.71
 ;;^UTILITY(U,$J,358.3,30870,2)
 ;;=^5003799
 ;;^UTILITY(U,$J,358.3,30871,0)
 ;;=G24.02^^123^1540^9
 ;;^UTILITY(U,$J,358.3,30871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30871,1,3,0)
 ;;=3^Medication-Induced Acute Dystonia
 ;;^UTILITY(U,$J,358.3,30871,1,4,0)
 ;;=4^G24.02
 ;;^UTILITY(U,$J,358.3,30871,2)
 ;;=^5003785
 ;;^UTILITY(U,$J,358.3,30872,0)
 ;;=G21.0^^123^1540^13
 ;;^UTILITY(U,$J,358.3,30872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30872,1,3,0)
 ;;=3^Neuroleptic Malignant Syndrome
 ;;^UTILITY(U,$J,358.3,30872,1,4,0)
 ;;=4^G21.0
 ;;^UTILITY(U,$J,358.3,30872,2)
 ;;=^5003771
 ;;^UTILITY(U,$J,358.3,30873,0)
 ;;=T50.905A^^123^1540^1
 ;;^UTILITY(U,$J,358.3,30873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30873,1,3,0)
 ;;=3^Adverse Effect of Unspec Medication,Init Encntr
 ;;^UTILITY(U,$J,358.3,30873,1,4,0)
 ;;=4^T50.905A
 ;;^UTILITY(U,$J,358.3,30873,2)
 ;;=^5052160
 ;;^UTILITY(U,$J,358.3,30874,0)
 ;;=T50.905D^^123^1540^3
 ;;^UTILITY(U,$J,358.3,30874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30874,1,3,0)
 ;;=3^Adverse Effect of Unspec Medication,Subseq Encntr
 ;;^UTILITY(U,$J,358.3,30874,1,4,0)
 ;;=4^T50.905D
 ;;^UTILITY(U,$J,358.3,30874,2)
 ;;=^5052161
 ;;^UTILITY(U,$J,358.3,30875,0)
 ;;=T50.905S^^123^1540^2
 ;;^UTILITY(U,$J,358.3,30875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30875,1,3,0)
 ;;=3^Adverse Effect of Unspec Medication,Sequela
 ;;^UTILITY(U,$J,358.3,30875,1,4,0)
 ;;=4^T50.905S
 ;;^UTILITY(U,$J,358.3,30875,2)
 ;;=^5052162
 ;;^UTILITY(U,$J,358.3,30876,0)
 ;;=F42.^^123^1541^7
 ;;^UTILITY(U,$J,358.3,30876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30876,1,3,0)
 ;;=3^Obsessive-Compulsive Disorder
 ;;^UTILITY(U,$J,358.3,30876,1,4,0)
 ;;=4^F42.
 ;;^UTILITY(U,$J,358.3,30876,2)
 ;;=^5003568
 ;;^UTILITY(U,$J,358.3,30877,0)
 ;;=F45.22^^123^1541^1
 ;;^UTILITY(U,$J,358.3,30877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30877,1,3,0)
 ;;=3^Body Dysmorphic Disorder
 ;;^UTILITY(U,$J,358.3,30877,1,4,0)
 ;;=4^F45.22
 ;;^UTILITY(U,$J,358.3,30877,2)
 ;;=^5003588
 ;;^UTILITY(U,$J,358.3,30878,0)
 ;;=F63.3^^123^1541^8
 ;;^UTILITY(U,$J,358.3,30878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30878,1,3,0)
 ;;=3^Trichotillomania
 ;;^UTILITY(U,$J,358.3,30878,1,4,0)
 ;;=4^F63.3
 ;;^UTILITY(U,$J,358.3,30878,2)
 ;;=^5003643
 ;;^UTILITY(U,$J,358.3,30879,0)
 ;;=L98.1^^123^1541^2
 ;;^UTILITY(U,$J,358.3,30879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30879,1,3,0)
 ;;=3^Excoriation (Skin-Picking) Disorder
 ;;^UTILITY(U,$J,358.3,30879,1,4,0)
 ;;=4^L98.1
 ;;^UTILITY(U,$J,358.3,30879,2)
 ;;=^186781
 ;;^UTILITY(U,$J,358.3,30880,0)
 ;;=F68.10^^123^1541^3
 ;;^UTILITY(U,$J,358.3,30880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30880,1,3,0)
 ;;=3^Factitious Disorder
 ;;^UTILITY(U,$J,358.3,30880,1,4,0)
 ;;=4^F68.10
 ;;^UTILITY(U,$J,358.3,30880,2)
 ;;=^5003663
 ;;^UTILITY(U,$J,358.3,30881,0)
 ;;=F63.9^^123^1541^5
